sorafenib has been researched along with betulinic acid in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (betulinic acid) | Trials (betulinic acid) | Recent Studies (post-2010) (betulinic acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,025 | 1 | 676 |
| Protein | Taxonomy | sorafenib (IC50) | betulinic acid (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 11.2 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 11.2 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 11.2 | |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2 | |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | 6.5 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 1.5 | |
| 5'-nucleotidase | Homo sapiens (human) | 7.28 | |
| Non-structural protein 1 | Dengue virus | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kutkowska, J; Rapak, A; Strzadala, L | 2 |
2 other study(ies) available for sorafenib and betulinic acid
| Article | Year |
|---|---|
Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.
Topics: A549 Cells; Apoptosis; Betulinic Acid; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Combined Modality Therapy; Drug Synergism; Flow Cytometry; Humans; Mutation; Niacinamide; Pentacyclic Triterpenes; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Sorafenib; Triterpenes | 2017 |
Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Betulinic Acid; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Synergism; Humans; Pancreatic Neoplasms; Pentacyclic Triterpenes; Sorafenib; Triterpenes; Tumor Stem Cell Assay | 2018 |